Andrea E van der Meulen-de Jong (Andrea van der Meulen-de Jong, Andrea E van der Meulen)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis Patients

Patient Reported

Magnetic Resonance Imaging

Top Venues

Crohn's & colitis 360

The American journal of gastroenterology

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Michiel T J Bak, Sebastiaan Ten Bokkel Huinink, Nicole Stephanie Erler, Alexander G L Bodelier, Gerard Dijkstra, Mariëlle J Romberg-Camps, Nanne K H De Boer, Frank Hoentjen, Laurents P S Stassen, Andrea E van der Meulen-de Jong, Rachel L West, Oddeke van Ruler, Christien J van der Woude, Annemarie C de Vries, null null, null null
Prognostic value of the modified Rutgeerts' score for long-term outcomes after primary ileocecal resection in Crohn's disease. The American journal of gastroenterology (2023)
Jeanine H C Arkenbosch, Joyce W Y Mak, Jacky C L Ho, Evelien M J Beelen, Nicole S Erler, Frank Hoentjen, Alexander G L Bodelier, Gerard Dijkstra, Mariëlle Romberg-Camps, Nanne K H de Boer, Laurents P S Stassen, Andrea E van der Meulen-de Jong, Rachel West, Oddeke van Ruler, Christien Janneke van der Woude, Siew C Ng, Annemarie C de Vries
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West. Inflammatory bowel diseases 28 (Suppl 2) (2022)
Emilie van Lingen, Sander van der Marel, P W Jeroen Maljaars, Josbert Keller, Andrea E van der Meulen-de Jong
Comment on Szczubełek et al. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients. Nutrients 2021, 13 , 4112. Nutrients 14 (9) (2022)
Marieke J Pierik, Andrea E van der Meulen-de Jong, Klaas Van der Linde, Maurice Lutgens, Johan Ph Kuyvenhoven, Halil Akol, Ids J Klompmaker, Michelle S G Sikkens, Yvonne J B van Megen, Corinne M Stoop, Joanne P J Bloemsaat-Minekus, Gerard Dijkstra
Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients. Crohn's & colitis 360 4 (3) (2021)
Marieke J Pierik, Andrea E van der Meulen-de Jong, Klaas Van der Linde, Maurice Lutgens, Johan Ph Kuyvenhoven, Halil Akol, Ids J Klompmaker, Michelle S G Sikkens, Yvonne J B van Megen, Corinne M Stoop, Joanne P J Bloemsaat-Minekus, Gerard Dijkstra
Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients. Crohn's & colitis 360 4 (3) (2021)